Daily non-political popular news in brief.

Sunshine pill for prostate cancer in 2009

A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the dangerous side-effects of a vitamin D overdose.

Read more »

Keywords: sunshine, pill, prostate, cancer, 2009

« Previous | Next »

Similar news on "Sunshine pill for prostate cancer in 2009":

1. Elderly, ill men get unneeded prostate cancer screenings
   11-14-2006 · EurekAlert!
   A study of almost 600,000 men aged 70 and older reveals that 56 percent had a routine prostate-specific antigen screening, a blood test for prostate cancer, even though no treatment guidelines recommend PSA screening for men of that age.
   Similar news · Read more »
   
2. Long-term financial costs associated with prostate cancer treatment
   12-21-2006 · EurekAlert!
   A new study reveals that the cumulative cost of prostate cancer is, on average, $42,570 over five years. Watchful waiting was the least expensive treatment while radiation and androgen deprivation therapy were the most expensive.
   Similar news · Read more »
   
3. Men with no sons more at risk for prostate cancer, according to Mailman School of PH Study
   01-03-2007 · EurekAlert!
   In a new study to determine if genes on the Y chromosome are involved in prostate cancer, researchers at the Mailman School of Public Health in conjunction with Hebrew University found that men who had only daughters had a higher risk of prostate cancer than men who had at least one son. The results further indicate that the relative risk of prostate cancer decreases as the number of sons increases.
   Similar news · Read more »
   
4. New class of targeted cancer drugs shows promise in slowing progression of recurrent prostate cancer
   02-16-2007 · EurekAlert!
   A new class of targeted anti-cancer drugs that blocks the human epidermal growth factor (HER) receptor family shows promise in prolonging the lives of patients with recurrent prostate cancer, a new Cedars-Sinai study shows.
   Similar news · Read more »
   
5. Inaugural issue of American Journal of Men's Health
   03-09-2007 · EurekAlert!
   Testicular cancer is the most common malignancy among 15-35 year-old young men. Men over 65 tend to get prostate cancer, the second leading cause of cancer death among American men. Researchers and physicians need to get as much information on these serious killers as possible so that men can be better informed; which is why the American Journal of Men's Health by SAGE, has published this research in its first issue debuting this month.
   Similar news · Read more »
   
6. Not just a menopausal symptom -- men have hot flashes, too
   04-13-2007 · EurekAlert!
   A new study in Psychophysiology confirms a surprising fact -- men who have undergone chemical castration for conditions such as prostate cancer experience hot flashes similar to those experienced by menopausal women. Using a technique called sternal skin conductance, doctors were able to positively identify hot flashes in males, a positive step toward providing therapy for those patients in need.
   Similar news · Read more »
   
7. MR imaging helps predict recurrence in prostate cancer patients
   05-04-2007 · EurekAlert!
   MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return, according to a recent study conducted by radiologists at the University of California-San Francisco.
   Similar news · Read more »
   
8. Brain-boosting pill alleviates post-chemotherapy fogginess
   06-03-2007 · EurekAlert!
   A drug described by some people as a "genius pill" for enhancing cognitive function provided relief to a small group of Rochester breast cancer survivors who were coping with a side effect known as "chemo-brain," according to a University of Rochester Medical Center study.
   Similar news · Read more »
   
9. Study identifies characteristics of clinicians likely to order inappropriate prostate screenings
   07-09-2007 · EurekAlert!
   Prostate-specific antigen tests to screen for prostate cancer are frequently performed among patients for whom the PSA test is not shown to be beneficial, and clinicians with certain characteristics are more likely to order such inappropriate screening tests, according to a report in the July 9 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
   Similar news · Read more »
   
10. Standard treatment for prostate cancer may encourage spread of disease
    10-01-2007 · EurekAlert!
    A popular prostate cancer treatment called androgen deprivation therapy may encourage prostate cancer cells to produce a protein that makes them more likely to spread throughout the body, a new study by Johns Hopkins researchers suggests.
    Similar news · Read more »